(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan has been accepted by the U.S. FDA for treating advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC) in patients who have previously received systemic therapies. The … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged advanced NSCLC, antibody-drug conjugate, AstraZeneca, Biologics License Application, BLA, breakthrough therapy designation, Daiichi Sankyo, datopotamab deruxtecan, drug approval, EGFR-mutated, EGFR-tyrosine kinase inhibitors, FDA, metastatic NSCLC, non-small cell lung cancer, NSCLC, objective response rate, oncology, partnership, Phase III Trials, Priority Review, safety profile, systemic therapies, TROP2-directed, TROPION-Lung01, TROPION-Lung05, TROPION-Lung14, TROPION-Lung15
(IN BRIEF) Sarclisa, an anti-CD38 treatment developed by Sanofi, has been approved in China for treating adult patients with relapsed or refractory multiple myeloma (R/R MM) who have received at least one prior therapy. The approval is based on the … Read the full press release
Posted in Business, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged anti-CD38 antibody, autologous stem cell transplant, bortezomib, CACA, Category I Recommendation, Chinese Anti-Cancer Association, Chinese Society of Clinical Oncology, clinical data, CSCO, dexamethasone, Global Head of Oncology, ICARIA-MM phase 3 study, innovative regulatory pathways, innovative therapies, IsaFiRsT real-world study, Lecheng Pilot Program, lenalidomide, local authorities, medical community, National Medical Products Administration, newly diagnosed multiple myeloma, NMPA, Olivier Nataf, overall response rate, overall survival, Pd, pomalidomide, R/R MM, real-world evidence, regulatory submission, relapsed or refractory multiple myeloma, RWE, Sanofi, Sanofi in China, Sarclisa
(IN BRIEF) A prototype of the Liverpool Diagnostic Infrared Wand (LDIR Wand), developed by the University of Liverpool in collaboration with the Liverpool Head and Neck Cancer Centre, has shown promising results in diagnosing oral cancer. The device uses a … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged cancer diagnosis, cancer prognosis, Cancer Research UK, clinical application, commercialization, early cancer detection, funding, haematoxylin and eosin staining, i4i programme, infrared spectral images, LDIR Wand, Liverpool Diagnostic Infrared Wand, Liverpool Head and Neck Cancer Centre, machine learning algorithm, National Institute for Health and Care Research, oral cancer, Professor Peter Weightman, Professor Richard Shaw, technological innovation, tissue analysis, University of Liverpool, “prototype”
(IN BRIEF) GSK has announced that the FDA has accepted its application to review a prefilled syringe version of Shingrix, its shingles vaccine. This new version, expected to be available from January 2025, eliminates the need for reconstitution, offering a … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology, United Kingdom
Tagged administration, adults 50 and over, antigen, AS01B adjuvant system, chickenpox, FDA, glycoprotein E, GSK, healthcare community, healthcare professionals, immune response, immunodeficiency, immunosuppression, liquid adjuvant, lyophilised, non-live vaccine, Prefilled Syringe, recombinant subunit vaccine, Recombinant Zoster Vaccine, reconstitution, RZV, safety, Shingles, shingles prevention, shingles vaccine, Shingrix, Shingrix approval, vaccine composition, Vaccine Innovation, vaccine presentation, vaccine safety, varicella, varicella-zoster virus
(IN BRIEF) Empa researchers have developed a groundbreaking 3D-printed, biodegradable fungal battery, capable of powering sensors for agriculture and research in remote regions. This living battery uses two types of fungi, a yeast fungus and a white rot fungus, to … Read the full press release
Posted in Business, Energy, Gas & Oil, Environment, Financial, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged 3D printed, 3D printing, agriculture, biodegradable, Carolina Reyes, cellulose, cellulose nutrients, electrical engineering, electricity, electrochemical techniques, Empa, fungal battery, fungi, Gebert Rüf Stiftung, Gustav Nyström, longevity, materials science, METABOLISM, microbial fuel cell, Microbials funding program, non-toxic, power, remote regions, RESEARCH, simple sugars, sustainability, sustainable power solutions, temperature sensor, white rot fungus, yeast fungus
(IN BRIEF) Alfa Laval has unveiled plans to open its Food Innovation Centre in Copenhagen, Denmark, by 2027. This new facility is part of the company’s capital investment strategy and aims to support the food industry in tackling the challenges … Read the full press release
Posted in Business, Denmark, Environment, Financial, Food & Beverage, Industrial, Infrastructure & Utilities, Investment, Management, News, Science, Sweden, Technology
Tagged 2027, academic institutions, AI, Alfa Laval, bio-solutions, capital expenditure, collaboration, Copenhagen, Copenhagen and Southern Sweden, Denmark, digitalization, efficiency, environmental impact, Food & Water Division, Food Innovation Centre, food producers, food production, food sector, future innovations, global corporations, global population, net-zero emissions, partnership, research and development, resilience, Sammy Hulpiau, start-ups, sustainability, technology
(IN BRIEF) Evonik has partnered with ST Pharm to enhance its RNA and nucleic acid therapeutic services, combining ST Pharm’s expertise in customized nucleic acids with Evonik’s advanced lipid and lipid nanoparticle (LNP) drug product development solutions. This collaboration aims … Read the full press release
Posted in Business, Chemicals, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged active ingredients, capping library screening, clinical trials, drug delivery, drug development, drug product development, enzymatic biotransformation, Evonik, Evonik capabilities, Fill & Finish, gene delivery, gene therapies, GMP manufacturing, Health Care Business, Kris S. Choi, life sciences sector, lipid nanoparticle, lipids, liposomes, LNP, mRNA development, mRNA-LNPs, North America manufacturing, nucleic acid medicines, nucleic acid therapeutics, nucleic acid therapies, Nutrition & Care division, oligonucleotides, partnership, pharmaceutical companies, RNA market, RNA therapeutics, siRNAs, small molecules, SmartCap® technology, South Korea, ST Pharm, strategic partnership, Yann d'Hervé
(IN BRIEF) Researchers at Empa and the Cantonal Hospital of St. Gallen are developing new nanocomplexes to combat antibiotic-resistant bacteria and protect eye tissue following cataract surgery. Supported by the Heinz A. Oertli Fund for Ophthalmology, these nanocomplexes, based on … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged Antibiotic-Resistant Infections, Empa, Eye Surgery, Mihyun Lee, Nanocomplexes, safety
(IN BRIEF) Roche has announced results from the Phase IIb PADOVA study evaluating prasinezumab in 586 individuals with early-stage Parkinson’s disease. While the primary endpoint of time to confirmed motor progression narrowly missed statistical significance, promising efficacy trends were observed, … Read the full press release
(IN BRIEF) BASF, alongside partners Endress+Hauser, TechnoCompound, and the Universities of Bayreuth and Jena, is leading the SpecReK project to enhance the mechanical recycling of plastics using advanced spectroscopic technology and AI. Funded by the German Federal Ministry of Education … Read the full press release
Posted in Artificial Intelligence (AI), Business, Chemicals, Education, Environment, Financial, Germany, Government, Industrial, Investment, Management, News, Science, Technology
Tagged AI, BASF, Dr. Bernhard von Vacano, Endress+Hauser, partnership, plastic recycling, SpecReK project, sustainability, TechnoCompound, Universities of Bayreuth and Jena
(IN BRIEF) Swisscom has expanded its data centre infrastructure in Western Switzerland by acquiring Philip Morris Products S.A.’s Bonvillars data centre near Yverdon-les-Bains. This move addresses the growing demand for secure and flexible colocation services while ensuring data storage remains … Read the full press release
Posted in Business, Financial, Industrial, Investment, Management, News, Science, Switzerland, Technology, Telecom
Tagged Data Centre Network, partnership, sustainability, Swisscom, Thomas Wettstein, Western Switzerland
(IN BRIEF) The University of Helsinki has launched a Doctoral Education Pilot to modernize doctoral training in response to societal and career demands. Part of a national program funding 1,000 three-year doctoral positions, the pilot aims to enhance researchers’ skills, … Read the full press release
Posted in Business, Education, Financial, Finland, Industrial, Investment, Management, News, Science, Technology
Tagged Doctoral Training, Eetu Halm, National Pilot Program, Rene Wong, University of Helsinki
(IN BRIEF) The University of York has assumed a leading role in advancing adult social care research, with Professor Yvonne Birks becoming the first director of the National Institute for Health and Care Research (NIHR) School for Social Care Research … Read the full press release
(IN BRIEF) Researchers from Empa and WSL have revealed significant opportunities to better utilize Switzerland’s wood resources, a key material for achieving net-zero emissions by 2050. Their study, part of the SCENE initiative, analyzed 2020 data and found that 40% … Read the full press release
Posted in Business, Environment, Financial, Industrial, Investment, Management, News, Science, Switzerland, Technology
Tagged Claudia Som, Empa, Nadia Malinverno, sustainability, Switzerland, Wood
(IN BRIEF) The European Society of Cardiology (ESC) has raised concerns over the growing incidence of cancer therapy-induced cardiovascular disease (CVD), warning of a potential cardio-oncology “epidemic” due to increasing cancer survival rates and aging populations. To address this, the … Read the full press release
Posted in Business, Financial, France, Healthcare, Industrial, Investment, Management, Media, News, Science, Technology
Tagged Cardio-Oncology Crisis, Dr. Alexander Lyon, Dr. Teresa López-Fernandez, ESC, health
(IN BRIEF) The FDA has granted Breakthrough Therapy designation to tolebrutinib for treating adults with non-relapsing secondary progressive multiple sclerosis (nrSPMS), following positive results from the HERCULES phase 3 study. The study showed tolebrutinib delayed disability progression by 31% and … Read the full press release
Posted in Business, Financial, France, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Dr. Erik Wallström, FDA, Progressive Multiple Sclerosis, safety, Sanofi, tolebrutinib
(IN BRIEF) Roche has received CE certification for its enhanced cobas® 6800/8800 systems 2.0, introducing significant improvements in laboratory diagnostics. The upgrade streamlines operations by reducing downtime, consolidating test menus, and increasing throughput, supported by innovative TAGS technology that detects … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged cobas Systems 2.0, Matt Sause, Molecular Diagnostics, Roche, safety
(IN BRIEF) Roche’s Vabysmo® (faricimab) prefilled syringe has received European Medicines Agency approval for treating three major retinal conditions: neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and macular edema caused by retinal vein occlusion (RVO). Serving over nine … Read the full press release
(IN BRIEF) A University of Liverpool study, funded by BSAVA PetSavers, examines the ageing process in dogs, identifying 12.5 years as the average age when veterinarians consider them senior, though this varies by breed. Smaller breeds like Jack Russell Terriers … Read the full press release
(IN BRIEF) Researchers from UCSF and the Technical University of Munich (TUM) have developed engineered regulatory immune cells to precisely modulate the immune system, addressing conditions like type 1 diabetes, autoimmune diseases, and organ transplant rejection. Unlike traditional immunosuppressants, this … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?